DrugId:  1
1. Name:  Velmanase alfa
2. Groups:  Investigational
3. Description:  Recombinant Human Alpha Mannosidase has been investigated for the treatment of Alpha Mannosidosis and Alpha-Mannosidosis.
4. Indication:  Not Available
DrugId:  2
1. Name:  (1Z)-2-HYDROXY-3-OXOHEX-1-EN-1-YL DIHYDROGEN PHOSPHATE
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  3
1. Name:  S-P-Nitrobenzyloxycarbonylglutathione
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  4
1. Name:  Delta-(L-Alpha-Aminoadipoyl)-L-Cysteinyl-D-Vinylglycine
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  5
1. Name:  S-Hydroxymethyl Glutathione
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  6
1. Name:  S-METHYL-GLUTATHIONE
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  7
1. Name:  Difelikefalin
2. Groups:  Investigational
3. Description:  Difelikefalin has been used in trials studying the treatment of Acute Pain and Postoperative Pain.
4. Indication:  Not Available
DrugId:  8
1. Name:  Foxy-5
2. Groups:  Investigational
3. Description:  Foxy-5 has been used in trials studying the treatment of Prostate Cancer, Colorectal Cancer, Metastatic Colon Cancer, Metastatic Breast Cancer, and Metastatic Prostate Cancer.
4. Indication:  Not Available
DrugId:  9
1. Name:  N-(1-Carboxy-3-Phenylpropyl)Phenylalanyl-Alpha-Asparagine
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  10
1. Name:  2-ACETYLAMINO-4-METHYL-PENTANOIC ACID [1-(1-FORMYL-PENTYLCARBAMOYL)-3-METHYL-BUTYL]-AMIDE
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  11
1. Name:  L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  12
1. Name:  R450
2. Groups:  Investigational
3. Description:  R450 is an alpha 1 antagonist that acts to tighten the muscle tone in the bladder. It is being considered for treatment of stress-related urinary incontinence. Phase IIa data for the drug show it reduced the number of incontinent episodes compared to placebo with minimal cardiovascular effects.
4. Indication:  Investigated for use/treatment in urinary incontinence.
DrugId:  13
1. Name:  AME-527
2. Groups:  Investigational
3. Description:  AME-527 is a humanized monoclonal antibody that recognizes human TNF-alpha (hTNF-alpha) with high affinity and specificity. AME-527 was generated by protein engineering and identified from a library of antibody variants based on its improved binding properties. 
4. Indication:  Investigated for use/treatment in rheumatoid arthritis.
DrugId:  14
1. Name:  N-[(BENZYLOXY)CARBONYL]-L-CYSTEINYLGLYCINE
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  15
1. Name:  S-(2,4-dinitrophenyl)glutathione
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  16
1. Name:  (9S,10S)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  17
1. Name:  S-(3-Iodobenzyl)Glutathione
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  18
1. Name:  GSHNA
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  19
1. Name:  alpha-Hydroxy glycineamide
2. Groups:  Investigational
3. Description:  Alpha-hydroxy glycineamide (αHGA) is the active antiviral metabolite of tri-peptide glycyl-prolyl-glycine-amide (GPG-NH2). αHGA inhibits the replication of HIV-1 in vitro by interfering with the capsid formation. It also has an effect on viral gp160 envelope protein. [3]
4. Indication:  Investigated for use/treatment in HIV infection.
DrugId:  20
1. Name:  Oxaloacetate Ion
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  21
1. Name:  Phenylpyruvic acid
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  22
1. Name:  5-phenyl-2-keto-valeric acid
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  23
1. Name:  [[1-[N-HYDROXY-ACETAMIDYL]-3-METHYL-BUTYL]-CARBONYL-LEUCINYL]-ALANINE ETHYL ESTER
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  24
1. Name:  S-Hexylglutathione
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  25
1. Name:  Sulfopyruvate
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
